Buzzberg Cup Bracket locked

Mad Money 06/22/26 | Audio Only

Watch on YouTube ↗  |  June 22, 2026 at 23:08  |  44:21  |  CNBC
Speakers
Jim Cramer — Host, Mad Money

Summary

Jim Cramer delivers an educational special on financial literacy, covering retirement accounts (401k, IRA, Roth IRA), the pitfalls of actively managed mutual funds, the benefits of low-cost S&P 500 index funds, 529 college savings plans, and basics of stock valuation. He also briefly mentions gold via GLD and shares a positive view on Eli Lilly.

  • Cramer explains the tax advantages and fee problems of 401k plans, recommending IRAs unless there is an employer match.
  • He highlights the impact of hidden 401k fees and limited fund choices on long-term returns.
  • Actively managed mutual funds are heavily criticized for high fees, underperformance, and asset-gathering incentives.
  • He advocates using low-cost S&P 500 index funds as the best passive investment for most people.
  • Roth IRAs and Roth 401ks are recommended for lower-income earners due to upfront tax savings and future tax-free growth.
  • 529 education savings plans are described as the best vehicle for college savings, with front-loading advantages.
  • Brief favorable mentions of GLD as a gold play and Eli Lilly for its growth dominance relative to Bristol-Myers.
  • Young investors are advised to take more risk and avoid bonds entirely.
Ideas
Jim Cramer Host, Mad Money 7:41
Cheap index fund beats most active managers.
A cheap S&P 500 index fund is the best passive investment, outperforming the vast majority of actively managed mutual funds after fees, and should be the core choice for investors who cannot pick individual stocks.
SPY HIGH
Jim Cramer Host, Mad Money 20:16
High fees, underperformance; avoid active funds.
Most actively managed mutual funds underperform their benchmarks, have high fees eroding returns, and suffer from misaligned incentives because managers prioritize asset gathering over performance.
actively managed mutual funds HIGH
Jim Cramer Host, Mad Money 42:15
Growth justifies valuation, biggest pharma ever.
Eli Lilly's superior growth rate makes its higher valuation acceptable, and the company could become the biggest pharmaceutical ever, making it preferable over peers like Bristol-Myers.
LLY MED
Up Next
28:43
A LIGAÇÃO QUE MUDOU COMPLETAMENTE A VIDA DE CLÓVIS DE BARROS
Market Makers · Jun 22
48:57
Oil Flows Through Hormuz, Fed Remembers Alan Greenspan | Bloomberg Businessweek Daily 6/22/2026
Bloomberg Markets · Jun 22
4:52
Why Warsh May Let Markets Tough It Out
Morgan Stanley · Jun 22
1:29:53
Tech Selloff Drags Stocks Lower | The Close 6/22/2026
Bloomberg Markets · Jun 22
45:48
New York Stock Market, Tech Stocks Lead Decline Expansion…Micron Rises Ahead of Earnings Release [Wall Street Newsletter]
3PRO TV (삼프로TV) · Jun 22

This CNBC video, published June 22, 2026, features Jim Cramer discussing SPY, actively managed mutual funds, LLY. 3 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Jim Cramer  · Tickers: SPY, actively managed mutual funds, LLY